BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lai KN, Li PK, Lui SF, Au TC, Tam JS, Tong KL, Lai FM. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med. 1991;324:1457-1463. [PMID: 2023605 DOI: 10.1056/nejm199105233242103] [Cited by in Crossref: 179] [Cited by in F6Publishing: 54] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang L, Meng H, Han X, Han C, Sun C, Ye F, Jin X. The relationship between HBV serum markers and the clinicopathological characteristics of hepatitis B virus-associated glomerulonephritis (HBV-GN) in the northeastern chinese population. Virol J 2012;9:200. [PMID: 22978266 DOI: 10.1186/1743-422X-9-200] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Akimoto T, Otake T, Tanaka A, Takahashi H, Higashizawa T, Inoue M, Nishino K, Saito O, Isoda N, Muto S, Sugano K, Kusano E. Steroid treatment in patients with membranous nephropathy and hepatitis B virus surface antigenemia: a report of two cases. Clin Exp Nephrol 2011;15:289-93. [PMID: 21170566 DOI: 10.1007/s10157-010-0391-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
3 Nobakht E, Cohen SD, Rosenberg AZ, Kimmel PL. HIV-associated immune complex kidney disease. Nat Rev Nephrol 2016;12:291-300. [PMID: 26782145 DOI: 10.1038/nrneph.2015.216] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 6.6] [Reference Citation Analysis]
4 Lee JG, Lee S, Kim YJ, Cho BM, Park JS, Kim HH, Cheong J, Jeong DW, Lee YH, Cho YH, Bae MJ, Choi EJ. Association of chronic viral hepatitis B with insulin resistance. World J Gastroenterol 2012; 18(42): 6120-6126 [PMID: 23155341 DOI: 10.3748/wjg.v18.i42.6120] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
5 Chen YC, Li CY, Tsai SJ, Chen YC. Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infection. World J Gastroenterol 2018; 24(8): 917-928 [PMID: 29491685 DOI: 10.3748/wjg.v24.i8.917] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
6 Fu B, Ji Y, Hu S, Ren T, Bhuva MS, Li G, Yang H. Efficacy and safety of anti-viral therapy for Hepatitis B virus-associated glomerulonephritis: A meta-analysis. PLoS One 2020;15:e0227532. [PMID: 31940324 DOI: 10.1371/journal.pone.0227532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Somlo F, Berry GR. Extrahepatic manifestations of hepatitis B virus infection: Addison's disease and myelofibrosis in a patient with persistent hepatitis B surface antigenemia. Can J Infect Dis 1993;4:139-44. [PMID: 22346436 DOI: 10.1155/1993/393861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
8 Chen YC, Su YC, Li CY, Hung SK. 13-year nationwide cohort study of chronic kidney disease risk among treatment-naïve patients with chronic hepatitis B in Taiwan. BMC Nephrol 2015;16:110. [PMID: 26199000 DOI: 10.1186/s12882-015-0106-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
9 Moroni G, Ponticelli C. Secondary Membranous Nephropathy. A Narrative Review. Front Med (Lausanne) 2020;7:611317. [PMID: 33344486 DOI: 10.3389/fmed.2020.611317] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 杨道坤, 孙屹峰, 梁海军, 申保生, 乔汉臣. 复方甘草酸苷联合拉米夫定治疗乙型肝炎相关性肾炎40例. 世界华人消化杂志 2010; 18(13): 1380-1383 [DOI: 10.11569/wcjd.v18.i13.1380] [Reference Citation Analysis]
11 Yang Y, Ma YP, Chen DP, Zhuo L, Li WG. A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous Nephropathy. PLoS One 2016;11:e0160437. [PMID: 27598699 DOI: 10.1371/journal.pone.0160437] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
12 Zhang Y, Zhou JH, Yin XL, Wang FY. Treatment of hepatitis B virus-associated glomerulonephritis: A meta-analysis. World J Gastroenterol 2010; 16(6): 770-777 [PMID: 20135728 DOI: 10.3748/wjg.v16.i6.770] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
13 Berchtold L, Zanetta G, Dahan K, Mihout F, Peltier J, Guerrot D, Brochériou I, Ronco P, Debiec H. Efficacy and Safety of Rituximab in Hepatitis B Virus-Associated PLA2R-Positive Membranous Nephropathy. Kidney Int Rep 2018;3:486-91. [PMID: 29725654 DOI: 10.1016/j.ekir.2017.09.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Sandhu BS, Sanyal AJ. Hepatorenal syndrome. Curr Treat Options Gastroenterol 2005;8:443-50. [PMID: 16313861 DOI: 10.1007/s11938-005-0030-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Cheng AY, Kong AP, Wong VW, So WY, Chan HL, Ho CS, Lam CW, Tam JS, Chow CC, Cockram CS. Chronic hepatitis B viral infection independently predicts renal outcome in type 2 diabetic patients. Diabetologia. 2006;49:1777-1784. [PMID: 16736132 DOI: 10.1007/s00125-006-0294-4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
16 Minemura M, Tajiri K, Shimizu Y. Systemic abnormalities in liver disease. World J Gastroenterol 2009; 15(24): 2960-2974 [PMID: 19554648 DOI: 10.3748/wjg.15.2960] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
17 Wong SN, Yu EC, Lok AS, Chan KW, Lau YL. Interferon treatment for hepatitis B-associated membranous glomerulonephritis in two Chinese children. Pediatr Nephrol 1992;6:417-20. [PMID: 1280987 DOI: 10.1007/BF00873997] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
18 Caliskan B, Yazici H, Caliskan Y, Ozluk Y, Gulluoglu M, Kilicaslan I, Turkmen A, Sever MS. The Effects of Helicobacter pylori Eradication on Proteinuria in Patients with Primary Glomerulonephritis. Int J Nephrol 2014;2014:180690. [PMID: 24707402 DOI: 10.1155/2014/180690] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
19 Mak LY, Liu SH, Yap DY, Seto WK, Wong DK, Fung J, Chan TM, Lai CL, Yuen MF. In Vitro and In Vivo Renoprotective Effects of Telbivudine in Chronic Hepatitis B Patients Receiving Nucleotide Analogue. Dig Dis Sci 2019;64:3630-41. [PMID: 31280390 DOI: 10.1007/s10620-019-05717-0] [Reference Citation Analysis]
20 Hibbs J, Young NS. Viruses, virulence and pathogenicity. Baillieres Clin Haematol 1995;8:1-23. [PMID: 7663043 DOI: 10.1016/s0950-3536(05)80230-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Pyrsopoulos NT, Reddy KR. Extrahepatic manifestations of chronic viral hepatitis. Curr Gastroenterol Rep. 2001;3:71-78. [PMID: 11177698 DOI: 10.1007/s11894-001-0044-1] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 3.3] [Reference Citation Analysis]
22 Liang TJ. Hepatitis B: the virus and disease. Hepatology. 2009;49:S13-S21. [PMID: 19399811 DOI: 10.1002/hep.22881] [Cited by in Crossref: 426] [Cited by in F6Publishing: 364] [Article Influence: 35.5] [Reference Citation Analysis]
23 Deray G, Buti M, Gane E, Jia J, Chan HLY, Craxi A, Piratvisuth T, Pol S. Hepatitis B Virus Infection and the Kidney: Renal Abnormalities in HBV Patients, Antiviral Drugs Handling, and Specific Follow-Up. Advances in Hepatology 2015;2015:1-11. [DOI: 10.1155/2015/596829] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Ndiaye AA, Fall IS, Lo G, Seck SM, Tall AB, Gueye B, Mbodj AB, Tal-Dia A. HBsAg seroprevalence among Senegalese militaries. Mil Med Res 2015;2:5. [PMID: 26000172 DOI: 10.1186/s40779-015-0032-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
25 Zheng XY, Wei RB, Tang L, Li P, Zheng XD. Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis. World J Gastroenterol 2012; 18(8): 821-832 [PMID: 22371643 DOI: 10.3748/wjg.v18.i8.821] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
26 Inoue T, Tanaka Y. Hepatitis B virus and its sexually transmitted infection - an update. Microb Cell 2016;3:420-37. [PMID: 28357379 DOI: 10.15698/mic2016.09.527] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 8.8] [Reference Citation Analysis]
27 Liang KH, Chen YC, Hsu CW, Chang ML, Yeh CT. Decrease of serum Angiotensin converting enzyme levels upon telbivudine treatment for chronic hepatitis B virus infection and negative correlations between the enzyme levels and estimated glumerular filtration rates. Hepat Mon. 2014;14:e15074. [PMID: 24596580 DOI: 10.5812/hepatmon.15074] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
28 Mweemba A, Zanolini A, Mulenga L, Emge D, Chi BH, Wandeler G, Vinikoor MJ. Chronic hepatitis B virus coinfection is associated with renal impairment among Zambian HIV-infected adults. Clin Infect Dis 2014;59:1757-60. [PMID: 25228705 DOI: 10.1093/cid/ciu734] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
29 Yang YM, Choi EJ. Renal safety of tenofovir and/or entecavir in patients with chronic HBV monoinfection. Ther Clin Risk Manag. 2017;13:1273-1285. [PMID: 29033575 DOI: 10.2147/tcrm.s143286] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 Moses PL, Krawitt EL, Aziz W, Corwin HL. Renal failure associated with hepatitis C virus infection. Improvement in renal function after treatment with interferon-alpha. Dig Dis Sci 1997;42:443-6. [PMID: 9052533 DOI: 10.1023/a:1018803027109] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
31 Charu V, Andeen N, Walavalkar V, Lapasia J, Kim JY, Lin A, Sibley R, Higgins J, Troxell M, Kambham N. Membranous nephropathy in patients with HIV: a report of 11 cases. BMC Nephrol 2020;21:401. [PMID: 32948130 DOI: 10.1186/s12882-020-02042-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Kong XL, Ma XJ, Su H, Xu DM. Relationship between occult hepatitis B virus infection and chronic kidney disease in a Chinese population-based cohort. Chronic Dis Transl Med 2016;2:55-60. [PMID: 29063026 DOI: 10.1016/j.cdtm.2016.07.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
33 Hong YS, Ryu S, Chang Y, Caínzos-Achirica M, Kwon MJ, Zhao D, Shafi T, Lazo M, Pastor-Barriuso R, Shin H, Cho J, Guallar E. Hepatitis B virus infection and development of chronic kidney disease: a cohort study. BMC Nephrol 2018;19:353. [PMID: 30537940 DOI: 10.1186/s12882-018-1154-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
34 Umbro I, Tinti F, Scalera I, Evison F, Gunson B, Sharif A, Ferguson J, Muiesan P, Mitterhofer AP. Acute kidney injury and post-reperfusion syndrome in liver transplantation. World J Gastroenterol 2016; 22(42): 9314-9323 [PMID: 27895419 DOI: 10.3748/wjg.v22.i42.9314] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
35 Chang CP, Su YC, Lin MC, Huang ST. Chinese Herbal Medicine Ameliorated the Development of Chronic Kidney Disease in Patients with Chronic Hepatitis C: A Retrospective Population-Based Cohort Study. Evid Based Complement Alternat Med 2019;2019:5319456. [PMID: 31871483 DOI: 10.1155/2019/5319456] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Hamid CK, Hameed RA, Khaliq BI, Manzoor R, Hamid CQ. HIV associated lupus like nephropathy. Ethiop J Health Sci 2014;24:277-83. [PMID: 25183936 DOI: 10.4314/ejhs.v24i3.13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
37 Das P, Vivek V, Ford M, Kingdon E, Holt S. Hepatitis B virus related membranous glomerulonephritis and proteinuria treated with lamivudine and tenofovir. BMJ Case Rep 2011;2011:bcr0520114287. [PMID: 22679045 DOI: 10.1136/bcr.05.2011.4287] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
38 Chan HL, Shaikh J, Gupta S, Hamed K. Renal Function in Nucleos(t)ide Analog-Treated Patients With Chronic Hepatitis B: A Systematic Literature Review and Network Meta-Analysis. Adv Ther. 2016;33:862-875. [PMID: 27146675 DOI: 10.1007/s12325-016-0337-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
39 Kataoka H, Mochizuki T, Akihisa T, Kawasoe K, Kawachi K, Makabe S, Sawada A, Manabe S, Sato M, Amemiya N, Mitobe M, Akanuma T, Ito Y, Inoue T, Suzuki T, Matsui K, Moriyama T, Horita S, Ohara M, Honda K, Nitta K. Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis: A case report. Medicine (Baltimore) 2019;98:e14014. [PMID: 30633192 DOI: 10.1097/MD.0000000000014014] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Lu H, Zhou J. HBV X gene transfection upregulates IL-1beta and IL-6 gene expression and induces rat glomerular mesangial cell proliferation. J Huazhong Univ Sci Technolog Med Sci 2008;28:247-50. [PMID: 18563316 DOI: 10.1007/s11596-008-0304-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
41 Nikolopoulou A, Teixeira C, Cook HT, Roufosse C, Cairns THD, Levy JB, Pusey CD, Griffith ME. Membranous nephropathy associated with viral infection. Clin Kidney J 2021;14:876-83. [PMID: 33777370 DOI: 10.1093/ckj/sfaa026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Banerjee S, Gunda P, Drake RF, Hamed K. Telbivudine for the treatment of chronic hepatitis B in HBeAg-positive patients in China: a health economic analysis. Springerplus 2016;5:1719. [PMID: 27777855 DOI: 10.1186/s40064-016-3404-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
43 Mocroft A, Neuhaus J, Peters L, Ryom L, Bickel M, Grint D, Koirala J, Szymczak A, Lundgren J, Ross MJ, Wyatt CM; INSIGHT SMART Study Group., ESPRIT Study Group. Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults. PLoS One 2012;7:e40245. [PMID: 22911697 DOI: 10.1371/journal.pone.0040245] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
44 Naicker S, Fabian J, Naidoo S, Wadee S, Paget G, Goetsch S. Infection and glomerulonephritis. Semin Immunopathol 2007;29:397-414. [PMID: 17846774 DOI: 10.1007/s00281-007-0088-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
45 Ponticelli C, Glassock RJ. Glomerular diseases: membranous nephropathy--a modern view. Clin J Am Soc Nephrol 2014;9:609-16. [PMID: 23813556 DOI: 10.2215/CJN.04160413] [Cited by in Crossref: 98] [Cited by in F6Publishing: 52] [Article Influence: 12.3] [Reference Citation Analysis]
46 Kamimura H, Setsu T, Kimura N, Yokoo T, Sakamaki A, Kamimura K, Tsuchiya A, Takamura M, Yamagiwa S, Terai S. Renal Impairment in Chronic Hepatitis B: A Review. Diseases. 2018;6. [PMID: 29921773 DOI: 10.3390/diseases6020052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Lai AS, Lai KN. Viral nephropathy. Nat Clin Pract Nephrol 2006;2:254-62. [PMID: 16932438 DOI: 10.1038/ncpneph0166] [Cited by in Crossref: 52] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
48 Nguyen MH, Lim JK, Burak Ozbay A, Fraysse J, Liou I, Meyer N, Dusheiko G, Gordon SC. Advancing Age and Comorbidity in a US Insured Population-Based Cohort of Patients With Chronic Hepatitis B. Hepatology. 2019;69:959-973. [PMID: 30175482 DOI: 10.1002/hep.30246] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 14.0] [Reference Citation Analysis]
49 Zhang Y, Zhang WL, Pang XW, Wang LX, Wei X, Huang CX, Bai XF, Han S, Liu LN, Lian JQ. Effect of 48-week pegylated interferon α-2a or nucleos(t)ide analogue therapy on renal function in Chinese patients with chronic hepatitis B. Virol J 2017;14:49. [PMID: 28274240 DOI: 10.1186/s12985-017-0712-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Chan TM. Hepatitis B and Renal Disease. Curr Hepat Rep 2010;9:99-105. [PMID: 20461128 DOI: 10.1007/s11901-010-0042-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
51 Hartleb M, Gutkowski K. Kidneys in chronic liver diseases. World J Gastroenterol 2012; 18(24): 3035-3049 [PMID: 22791939 DOI: 10.3748/wjg.v18.i24.3035] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
52 Si J, Yu C, Guo Y, Bian Z, Qin C, Yang L, Chen Y, Yin L, Li H, Lan J, Chen J, Chen Z, Lv J, Li L;  China Kadoorie Biobank Collaborative Group. Chronic hepatitis B virus infection and risk of chronic kidney disease: a population-based prospective cohort study of 0.5 million Chinese adults. BMC Med. 2018;16:93. [PMID: 29909773 DOI: 10.1186/s12916-018-1084-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
53 Chen Q, Ning Z, Wang L, Ying H, Dong S, Zhang C, Shen X, Guo Y, Chen H, Zhu X, Shen Y, Shi W, Hua Y, Wang K, Lin J, Xu L, Chen L, Feng L, Zhang X, Xie J, Sun B, Sun Y, Gu W, Kang M, Tang Z, Chen Z, Chen Z, Liu L, Yu J, Li Z, Meng Z. Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter cohort study. Oncotarget 2016;7:85603-12. [PMID: 27811354 DOI: 10.18632/oncotarget.13000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Sun IO, Hong YA, Park HS, Choi SR, Chung BH, Park CW, Yang CW, Kim YS, Choi BS. Experience of anti-viral therapy in hepatitis B-associated membranous nephropathy, including Lamivudine-resistant strains. Korean J Intern Med 2012;27:411-6. [PMID: 23269882 DOI: 10.3904/kjim.2012.27.4.411] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]